Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
7.46M
-
Shares change
-
+285K
-
Total reported value, excl. options
-
$422M
-
Value change
-
+$13.6M
-
Put/Call ratio
-
0.82
-
Number of buys
-
81
-
Number of sells
-
-78
-
Price
-
$56.54
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2018
200 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2018.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.46M shares
of 22.3M outstanding shares and own 33.49% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.39M shares), Vanguard Group Inc (523K shares), MANGROVE PARTNERS (512K shares), DIMENSIONAL FUND ADVISORS LP (512K shares), LSV ASSET MANAGEMENT (295K shares), NOMURA HOLDINGS INC (277K shares), STATE STREET CORP (270K shares), FIRST MANHATTAN CO (216K shares), RENAISSANCE TECHNOLOGIES LLC (178K shares), and Invesco Ltd. (174K shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.